Last updated: June 1, 2026

TL;DR

Clinical-strength aluminum chloride antiperspirant is the first-line OTC treatment for hyperhidrosis recommended by the American Academy of Dermatology. For excessive underarm, hand, or foot sweating, the correct formula applied correctly at night produces the most significant reduction available without a prescription. DryDry is a Swedish-made clinical-strength option with over 5 million units sold across European markets since 2006.

What is hyperhidrosis and who does it affect?

Hyperhidrosis is excessive sweating that goes beyond what the body needs for temperature regulation. According to sweathelp.org, the International Hyperhidrosis Society estimates that approximately 5 percent of people worldwide experience hyperhidrosis. The condition affects specific body areas, most commonly the underarms, palms, and soles of the feet, in its primary form, which has no underlying medical cause.

The impact is primarily practical and social. Shirts soaked through before mid-morning, wet handshakes, slipping grip on equipment, avoidance of social situations involving physical contact; these are the daily realities for people with untreated hyperhidrosis. The condition is not dangerous, but it is consistently disruptive in ways that standard hygiene products cannot address.

According to the American Academy of Dermatology, hyperhidrosis affects people of all ages and is significantly underreported because many sufferers assume nothing effective is available, or feel embarrassed to raise it with a physician. A large proportion of people with hyperhidrosis have never tried clinical-strength topical treatment correctly.

Why is aluminum chloride the first-line treatment for hyperhidrosis?

Aluminum chloride addresses hyperhidrosis at the source: the sweat gland itself. Applied to dry skin overnight, it reacts with proteins inside the sweat duct to form a physical gel plug that reduces the volume of sweat the gland can produce. This is not a masking or absorbing mechanism; it is a direct reduction in output at the gland level, which is why it produces results that deodorants and weaker antiperspirants cannot match.

The American Academy of Dermatology identifies clinical-strength aluminum chloride antiperspirant as the recommended first-line OTC treatment for hyperhidrosis. The AAD's treatment ladder puts topical aluminum chloride at step one, before iontophoresis, prescription formulas, or botulinum toxin injections. Starting with the strongest available OTC formula and applying it correctly resolves hyperhidrosis to an acceptable level for a significant proportion of people, without escalating to clinical procedures.

A peer-reviewed reference at NCBI StatPearls similarly lists topical aluminum chloride as a first-line option for hyperhidrosis across affected body areas.

Which DryDry formula is right for hyperhidrosis?

The correct starting formula depends on the severity of sweating and skin tolerance, not on any one-size-fits-all recommendation.

For most people with hyperhidrosis, start with the Original. The DryDry Original contains aluminum chloride at the highest concentration in the product range and is designed to last up to 7 days per application. For someone who sweats heavily and has not experienced significant skin sensitivity with other antiperspirants, the Original is the correct first choice. Lower-concentration formulas will typically provide insufficient control for clinical-grade hyperhidrosis.

For reactive or sensitive skin, start with the Sensitive. The DryDry Sensitive is alcohol-free and contains aluminum chloride at a lower concentration. It provides approximately 48 hours of clinical-strength protection and is appropriate for people who have experienced irritation from alcohol-based formulas or whose skin reacts to high concentrations. It delivers clinical-strength sweat control, just at a shorter duration per application. The sensitive skin comparison is in Clinical Antiperspirant for Sensitive Skin.

For multiple body areas, the same formulas apply. Palmar hyperhidrosis (sweaty palms) and plantar hyperhidrosis (sweaty feet) respond to the same aluminum chloride mechanism. The Original Dab-on can be applied to palms and the Foot Spray addresses plantar sweating. DryDry's product range is specifically designed to cover all the primary hyperhidrosis-affected body areas under one brand.

How do you apply antiperspirant correctly for hyperhidrosis?

Incorrect application is the most common reason clinical-strength antiperspirant fails for hyperhidrosis sufferers. Most people apply it in the morning after a shower, the same way they would use a standard deodorant. This is the wrong method for clinical-strength formulas.

The correct protocol:

  1. Apply in the evening on completely dry skin. After a shower, wait until the application area is fully dry, not just towel-dry. Residual moisture prevents the aluminum chloride from penetrating efficiently.
  2. Apply a thin, even layer. More product does not improve results. A thin layer on dry skin is what the formula is designed for.
  3. Allow 3 to 5 minutes to dry. Do not put on a shirt immediately.
  4. Sleep with the formula in place. The 6 to 8 hours of overnight dry contact is when the gel plug forms inside the sweat duct.
  5. Rinse off in the morning shower. The surface residue washes away. The protective gel plug inside the duct does not.
  6. Apply on two consecutive evenings in the first week. The second application deepens the protective layer. Skipping the second night is the most common cause of underwhelming first-week results.

The full routine with common application mistakes is in How to Apply Clinical-Strength Antiperspirant.

What if clinical-strength antiperspirant is not enough for your hyperhidrosis?

A 4 to 6 week trial of correct clinical-strength application is the standard evaluation period before concluding OTC treatment is insufficient. If breakthrough sweating persists after that period with correct application on a maintenance schedule, the next options on the treatment ladder are:

  • Prescription-strength aluminum chloride formula. Higher concentrations than OTC products, available through a dermatologist.
  • Iontophoresis. A device that passes a mild electrical current through water into the skin. Particularly effective for palmar and plantar hyperhidrosis per the AAD. Requires multiple sessions per week initially, then maintenance.
  • Botulinum toxin injections. Injected into the affected area to temporarily block sweat-gland nerve signals. Effects last 4 to 12 months. Used for underarms and palms when topical and iontophoresis approaches are insufficient.
  • Oral medications. Anticholinergic medications reduce nerve signaling to sweat glands systemically but carry systemic side effects. Reserved for cases where localized treatments are inadequate.

Before escalating, it is worth confirming that the OTC trial was done with the highest appropriate concentration (Original, not Light or Sensitive, for most hyperhidrosis cases) and that all three application conditions were correct: dry skin, evening timing, and two-night loading. The failure diagnosis guide is in When Pharmacy Antiperspirant Fails: What to Try.

Frequently asked questions

Is hyperhidrosis a medical condition that needs a diagnosis?

Primary hyperhidrosis does not require a formal diagnosis to begin OTC treatment. The American Academy of Dermatology recommends starting with clinical-strength topical aluminum chloride when sweating is heavy, persistent, and affects daily life. A physician visit is appropriate if sweating started suddenly, occurs during sleep, or is accompanied by other symptoms; those patterns may suggest a secondary cause that requires investigation.

Can hyperhidrosis be controlled with antiperspirant?

Clinical-strength antiperspirant controls hyperhidrosis during the active protection window. It reduces sweat output while the gel plug is in place and requires ongoing maintenance application to sustain that effect. For primary hyperhidrosis, which has no underlying medical cause, OTC management on a maintenance schedule is the practical long-term approach for most people: effective control, not a cure.

What is the strongest OTC antiperspirant for hyperhidrosis in Europe?

DryDry Original contains aluminum chloride at the highest concentration in the DryDry product range and is designed to last up to 7 days per application. It is a European-formulated clinical-strength product available across European markets through drydrystore.com. Results vary by individual. For those whose skin cannot tolerate the Original, the DryDry Sensitive is the alcohol-free alternative with approximately 48 hours of protection per application.

Does hyperhidrosis get worse with age?

Primary hyperhidrosis often begins in adolescence or early adulthood and can vary in intensity over time. Some people find it improves after middle age; others find it remains consistent or fluctuates with life changes, stress levels, or hormonal shifts. Managing it with clinical-strength antiperspirant on a maintenance schedule provides consistent control regardless of how baseline severity changes over time.

Is antiperspirant safe for daily use with hyperhidrosis?

Clinical-strength formulas are not designed or needed for daily application. DryDry Original is designed to last up to 7 days per application. After the initial two-night loading period, once or twice per week maintains protection. Daily application is unnecessary and increases the risk of skin irritation. For hyperhidrosis management, a consistent weekly schedule is more effective than daily use.

Clinical-strength antiperspirant for hyperhidrosis

The DryDry Original Dab-on (35ml, €18.99) is the clinical-strength first-line OTC option for hyperhidrosis, designed to last up to 7 days per application; results vary by individual. Available across European markets through drydrystore.com.

Get DryDry Original →

Christopher Andersson is Founder and CEO of DryDry, a Swedish-made clinical-strength antiperspirant brand for heavy sweating. With 20+ years of experience in the personal care industry, Christopher leads a brand that has sold over 5 million units across European markets since 2006.